Houot R, Bachy E, Cartron G, Gros FX, et al. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nat Med 2023 Oct 9. doi: 10.1038/s41591-023-02624.
PMID: 37814064